Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.
Identifieur interne : 002368 ( Ncbi/Merge ); précédent : 002367; suivant : 002369Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.
Auteurs : Han-Xin Lin [Canada] ; Yan Feng ; Xinming Tu ; Xuesen Zhao ; Chih-Heng Hsieh ; Lauren Griffin ; Murray Junop ; Chengsheng ZhangSource :
- Virus research [ 1872-7492 ] ; 2011.
Descripteurs français
- KwdFr :
- Coronavirus humain NL63 (génétique), Coronavirus humain NL63 (physiologie), Délétion de séquence, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (génétique), Glycoprotéines membranaires (métabolisme), Humains, Liaison aux protéines, Lignée cellulaire, Protéines de l'enveloppe virale (génétique), Protéines de l'enveloppe virale (métabolisme), Protéines mutantes (génétique), Protéines mutantes (métabolisme), Pénétration virale, Récepteurs viraux (métabolisme), Substitution d'acide aminé.
- MESH :
- génétique : Coronavirus humain NL63, Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines mutantes.
- métabolisme : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines mutantes, Récepteurs viraux.
- physiologie : Coronavirus humain NL63.
- Délétion de séquence, Glycoprotéine de spicule des coronavirus, Humains, Liaison aux protéines, Lignée cellulaire, Pénétration virale, Substitution d'acide aminé.
English descriptors
- KwdEn :
- Amino Acid Substitution, Cell Line, Coronavirus NL63, Human (genetics), Coronavirus NL63, Human (physiology), Humans, Membrane Glycoproteins (genetics), Membrane Glycoproteins (metabolism), Mutant Proteins (genetics), Mutant Proteins (metabolism), Protein Binding, Receptors, Virus (metabolism), Sequence Deletion, Spike Glycoprotein, Coronavirus, Viral Envelope Proteins (genetics), Viral Envelope Proteins (metabolism), Virus Internalization.
- MESH :
- chemical , genetics : Membrane Glycoproteins, Mutant Proteins, Viral Envelope Proteins.
- genetics : Coronavirus NL63, Human.
- chemical , metabolism : Membrane Glycoproteins, Mutant Proteins, Receptors, Virus, Viral Envelope Proteins.
- physiology : Coronavirus NL63, Human.
- Amino Acid Substitution, Cell Line, Humans, Protein Binding, Sequence Deletion, Spike Glycoprotein, Coronavirus, Virus Internalization.
Abstract
The spike (S) protein of human coronavirus NL63 (HCoV-NL63) mediates both cell attachment by binding to its receptor hACE2 and membrane fusion during virus entry. We have previously identified the receptor-binding domain (RBD) and residues important for RBD-hACE2 association. Here, we further characterized the S protein by investigating the roles of the cytoplasmic tail and 19 residues located in the RBD in protein accumulation, receptor binding, and pseudotype virus entry. For these purposes, we first identified an entry-efficient S gene template from a pool of gene variants and used it as a backbone to generate a series of cytoplasmic tail deletion and single residue substitution mutants. Our results showed that: (i) deletion of 18aa from the C-terminus enhanced the S protein accumulation and virus entry, which might be due to the deletion of intracellular retention signals; (ii) further deletion to residue 29 also enhanced the amount of S protein on the cell surface and in virion, but reduced virus entry by 25%, suggesting that residues 19-29 contributes to membrane fusion; (iii) a 29aa-deletion mutant had a defect in anchoring on the plasma membrane, which led to a dramatic decrease of S protein in virion and virus entry; (iv) a total of 15 residues (Y498, V499, V531, G534, G537, D538, S540, G575, S576, E582, W585, Y590, T591, V593 and G594) within RBD were important for receptor binding and virus entry. They probably form three receptor binding motifs, and the third motif is conserved between NL63 and SARS-CoV.
DOI: 10.1016/j.virusres.2011.06.029
PubMed: 21798295
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001487
- to stream PubMed, to step Curation: 001487
- to stream PubMed, to step Checkpoint: 001526
Links to Exploration step
pubmed:21798295Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.</title>
<author><name sortKey="Lin, Han Xin" sort="Lin, Han Xin" uniqKey="Lin H" first="Han-Xin" last="Lin">Han-Xin Lin</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Molecular Medicine, McMaster University, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Molecular Medicine, McMaster University</wicri:regionArea>
<placeName><settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université McMaster</orgName>
</affiliation>
</author>
<author><name sortKey="Feng, Yan" sort="Feng, Yan" uniqKey="Feng Y" first="Yan" last="Feng">Yan Feng</name>
</author>
<author><name sortKey="Tu, Xinming" sort="Tu, Xinming" uniqKey="Tu X" first="Xinming" last="Tu">Xinming Tu</name>
</author>
<author><name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
</author>
<author><name sortKey="Hsieh, Chih Heng" sort="Hsieh, Chih Heng" uniqKey="Hsieh C" first="Chih-Heng" last="Hsieh">Chih-Heng Hsieh</name>
</author>
<author><name sortKey="Griffin, Lauren" sort="Griffin, Lauren" uniqKey="Griffin L" first="Lauren" last="Griffin">Lauren Griffin</name>
</author>
<author><name sortKey="Junop, Murray" sort="Junop, Murray" uniqKey="Junop M" first="Murray" last="Junop">Murray Junop</name>
</author>
<author><name sortKey="Zhang, Chengsheng" sort="Zhang, Chengsheng" uniqKey="Zhang C" first="Chengsheng" last="Zhang">Chengsheng Zhang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21798295</idno>
<idno type="pmid">21798295</idno>
<idno type="doi">10.1016/j.virusres.2011.06.029</idno>
<idno type="wicri:Area/PubMed/Corpus">001487</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001487</idno>
<idno type="wicri:Area/PubMed/Curation">001487</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001487</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001526</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001526</idno>
<idno type="wicri:Area/Ncbi/Merge">002368</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.</title>
<author><name sortKey="Lin, Han Xin" sort="Lin, Han Xin" uniqKey="Lin H" first="Han-Xin" last="Lin">Han-Xin Lin</name>
<affiliation wicri:level="4"><nlm:affiliation>Department of Pathology and Molecular Medicine, McMaster University, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Molecular Medicine, McMaster University</wicri:regionArea>
<placeName><settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université McMaster</orgName>
</affiliation>
</author>
<author><name sortKey="Feng, Yan" sort="Feng, Yan" uniqKey="Feng Y" first="Yan" last="Feng">Yan Feng</name>
</author>
<author><name sortKey="Tu, Xinming" sort="Tu, Xinming" uniqKey="Tu X" first="Xinming" last="Tu">Xinming Tu</name>
</author>
<author><name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
</author>
<author><name sortKey="Hsieh, Chih Heng" sort="Hsieh, Chih Heng" uniqKey="Hsieh C" first="Chih-Heng" last="Hsieh">Chih-Heng Hsieh</name>
</author>
<author><name sortKey="Griffin, Lauren" sort="Griffin, Lauren" uniqKey="Griffin L" first="Lauren" last="Griffin">Lauren Griffin</name>
</author>
<author><name sortKey="Junop, Murray" sort="Junop, Murray" uniqKey="Junop M" first="Murray" last="Junop">Murray Junop</name>
</author>
<author><name sortKey="Zhang, Chengsheng" sort="Zhang, Chengsheng" uniqKey="Zhang C" first="Chengsheng" last="Zhang">Chengsheng Zhang</name>
</author>
</analytic>
<series><title level="j">Virus research</title>
<idno type="eISSN">1872-7492</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Cell Line</term>
<term>Coronavirus NL63, Human (genetics)</term>
<term>Coronavirus NL63, Human (physiology)</term>
<term>Humans</term>
<term>Membrane Glycoproteins (genetics)</term>
<term>Membrane Glycoproteins (metabolism)</term>
<term>Mutant Proteins (genetics)</term>
<term>Mutant Proteins (metabolism)</term>
<term>Protein Binding</term>
<term>Receptors, Virus (metabolism)</term>
<term>Sequence Deletion</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (metabolism)</term>
<term>Virus Internalization</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Coronavirus humain NL63 (génétique)</term>
<term>Coronavirus humain NL63 (physiologie)</term>
<term>Délétion de séquence</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (génétique)</term>
<term>Glycoprotéines membranaires (métabolisme)</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Protéines mutantes (génétique)</term>
<term>Protéines mutantes (métabolisme)</term>
<term>Pénétration virale</term>
<term>Récepteurs viraux (métabolisme)</term>
<term>Substitution d'acide aminé</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Mutant Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Coronavirus NL63, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Coronavirus humain NL63</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines mutantes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Membrane Glycoproteins</term>
<term>Mutant Proteins</term>
<term>Receptors, Virus</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines mutantes</term>
<term>Récepteurs viraux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Coronavirus humain NL63</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Coronavirus NL63, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Substitution</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Protein Binding</term>
<term>Sequence Deletion</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Virus Internalization</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Délétion de séquence</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Liaison aux protéines</term>
<term>Lignée cellulaire</term>
<term>Pénétration virale</term>
<term>Substitution d'acide aminé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The spike (S) protein of human coronavirus NL63 (HCoV-NL63) mediates both cell attachment by binding to its receptor hACE2 and membrane fusion during virus entry. We have previously identified the receptor-binding domain (RBD) and residues important for RBD-hACE2 association. Here, we further characterized the S protein by investigating the roles of the cytoplasmic tail and 19 residues located in the RBD in protein accumulation, receptor binding, and pseudotype virus entry. For these purposes, we first identified an entry-efficient S gene template from a pool of gene variants and used it as a backbone to generate a series of cytoplasmic tail deletion and single residue substitution mutants. Our results showed that: (i) deletion of 18aa from the C-terminus enhanced the S protein accumulation and virus entry, which might be due to the deletion of intracellular retention signals; (ii) further deletion to residue 29 also enhanced the amount of S protein on the cell surface and in virion, but reduced virus entry by 25%, suggesting that residues 19-29 contributes to membrane fusion; (iii) a 29aa-deletion mutant had a defect in anchoring on the plasma membrane, which led to a dramatic decrease of S protein in virion and virus entry; (iv) a total of 15 residues (Y498, V499, V531, G534, G537, D538, S540, G575, S576, E582, W585, Y590, T591, V593 and G594) within RBD were important for receptor binding and virus entry. They probably form three receptor binding motifs, and the third motif is conserved between NL63 and SARS-CoV.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21798295</PMID>
<DateCompleted><Year>2011</Year>
<Month>12</Month>
<Day>16</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>160</Volume>
<Issue>1-2</Issue>
<PubDate><Year>2011</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Virus research</Title>
<ISOAbbreviation>Virus Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.</ArticleTitle>
<Pagination><MedlinePgn>283-93</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2011.06.029</ELocationID>
<Abstract><AbstractText>The spike (S) protein of human coronavirus NL63 (HCoV-NL63) mediates both cell attachment by binding to its receptor hACE2 and membrane fusion during virus entry. We have previously identified the receptor-binding domain (RBD) and residues important for RBD-hACE2 association. Here, we further characterized the S protein by investigating the roles of the cytoplasmic tail and 19 residues located in the RBD in protein accumulation, receptor binding, and pseudotype virus entry. For these purposes, we first identified an entry-efficient S gene template from a pool of gene variants and used it as a backbone to generate a series of cytoplasmic tail deletion and single residue substitution mutants. Our results showed that: (i) deletion of 18aa from the C-terminus enhanced the S protein accumulation and virus entry, which might be due to the deletion of intracellular retention signals; (ii) further deletion to residue 29 also enhanced the amount of S protein on the cell surface and in virion, but reduced virus entry by 25%, suggesting that residues 19-29 contributes to membrane fusion; (iii) a 29aa-deletion mutant had a defect in anchoring on the plasma membrane, which led to a dramatic decrease of S protein in virion and virus entry; (iv) a total of 15 residues (Y498, V499, V531, G534, G537, D538, S540, G575, S576, E582, W585, Y590, T591, V593 and G594) within RBD were important for receptor binding and virus entry. They probably form three receptor binding motifs, and the third motif is conserved between NL63 and SARS-CoV.</AbstractText>
<CopyrightInformation>Copyright © 2011 Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName>
<ForeName>Han-Xin</ForeName>
<Initials>HX</Initials>
<AffiliationInfo><Affiliation>Department of Pathology and Molecular Medicine, McMaster University, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Feng</LastName>
<ForeName>Yan</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tu</LastName>
<ForeName>Xinming</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Xuesen</ForeName>
<Initials>X</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hsieh</LastName>
<ForeName>Chih-Heng</ForeName>
<Initials>CH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Griffin</LastName>
<ForeName>Lauren</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Junop</LastName>
<ForeName>Murray</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Chengsheng</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>MOP53209</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
<Grant><GrantID>MOP68955</GrantID>
<Agency>Canadian Institutes of Health Research</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>07</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Virus Res</MedlineTA>
<NlmUniqueID>8410979</NlmUniqueID>
<ISSNLinking>0168-1702</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578553">MHV surface projection glycoprotein</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C578557">spike glycoprotein, SARS-CoV</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058957" MajorTopicYN="N">Coronavirus NL63, Human</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017384" MajorTopicYN="N">Sequence Deletion</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053586" MajorTopicYN="Y">Virus Internalization</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>03</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2011</Year>
<Month>06</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>06</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>12</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21798295</ArticleId>
<ArticleId IdType="pii">S0168-1702(11)00253-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.virusres.2011.06.029</ArticleId>
<ArticleId IdType="pmc">PMC7114368</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5913-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 Feb;80(3):1280-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16415005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2005 Jul 7;436(7047):112-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16001071</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2006 Feb 10;281(6):3198-203</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16339146</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1981 Jul 15;112(1):355-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6166122</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Oct 15;279(42):43661-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15304515</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2005 Jun 15;40(12):1721-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15909257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Pediatr Infect Dis J. 2010 Sep;29(9):822-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20720471</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2009 May;15(5):806-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19402976</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Oct;78(19):10628-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15367630</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Nov;79(21):13209-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16227244</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Sep;78(17):9007-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15308697</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2008 Jun;82(12):6078-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18400867</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19970-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19901337</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2005 Oct;79(20):12905-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16188992</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Emerg Infect Dis. 2005 Aug;11(8):1225-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16102311</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virus Res. 2005 Feb;107(2):129-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15649559</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2001 Jan 20;279(2):371-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11162792</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2011 Jun;85(11):5331-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21411533</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Feb 15;191(4):503-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655772</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6212-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15073334</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2004 Jan 30;279(5):3197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14670965</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2007 Nov 1;196(9):1321-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17922396</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Virol. 2007 Jan;38(1):27-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17137835</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Eur J Pediatr. 2008 Jan;167(1):75-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17297612</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Med. 2005 Aug;2(8):e240</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16104827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 May 31;102(22):7988-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15897467</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(12):6134-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15163706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EMBO J. 2005 Apr 20;24(8):1634-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15791205</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2009 Jul;90(Pt 7):1724-1729</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19264610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Virus Res. 2006;66:193-292</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16877062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Feb;74(3):1566-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10627571</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEMS Microbiol Rev. 2006 Sep;30(5):760-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16911043</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2000 Feb;81(Pt 2):489-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10644848</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2006 Feb;80(3):1302-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16415007</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2005 Mar;75(3):455-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15648064</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18490652</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4240-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15010527</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2008 Nov;89(Pt 11):2741-2745</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18931070</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bone Marrow Transplant. 2010 Jun;45(6):1115-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19820731</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2005 Aug;86(Pt 8):2269-2274</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16033974</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2000 Mar 30;269(1):212-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10725213</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Apr 10;360(2):264-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17134730</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1997 Jan 20;227(2):378-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9018137</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2005 Mar;75(3):463-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15648061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15572765</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Cell. 2003 Jan 24;112(2):141-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12553900</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2005 Sep 16;309(5742):1864-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16166518</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Sep;78(18):9904-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15331724</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2004 Apr;10(4):368-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15034574</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2008 Apr;89(Pt 4):1015-1024</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18343844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Infect Dis. 2005 Feb 15;191(4):492-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15655770</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2008 Mar 15;372(2):221-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18063004</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2005 Apr 10;334(2):306-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15780881</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Med. 2005 Aug;11(8):875-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16007097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2006 Dec 26;45(51):15205-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17176042</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2008 May;80(5):906-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18360904</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Virol. 2006 Jul;78(7):938-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16721849</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Clin Microbiol Infect. 2006 Nov;12(11):1089-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17002608</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 2005 Aug 19;280(33):29588-95</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15980414</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>BMC Infect Dis. 2005 Feb 01;5:6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15686594</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2007 Oct 25;367(2):367-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17631932</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2002 May 25;359(9320):1832-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12044382</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Sep 3;321(4):994-1000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15358126</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Adv Virus Res. 2005;64:165-230</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16139595</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2010 Jan;84(2):1198-205</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19864379</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Hamilton (Ontario)</li>
</settlement>
<orgName><li>Université McMaster</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Feng, Yan" sort="Feng, Yan" uniqKey="Feng Y" first="Yan" last="Feng">Yan Feng</name>
<name sortKey="Griffin, Lauren" sort="Griffin, Lauren" uniqKey="Griffin L" first="Lauren" last="Griffin">Lauren Griffin</name>
<name sortKey="Hsieh, Chih Heng" sort="Hsieh, Chih Heng" uniqKey="Hsieh C" first="Chih-Heng" last="Hsieh">Chih-Heng Hsieh</name>
<name sortKey="Junop, Murray" sort="Junop, Murray" uniqKey="Junop M" first="Murray" last="Junop">Murray Junop</name>
<name sortKey="Tu, Xinming" sort="Tu, Xinming" uniqKey="Tu X" first="Xinming" last="Tu">Xinming Tu</name>
<name sortKey="Zhang, Chengsheng" sort="Zhang, Chengsheng" uniqKey="Zhang C" first="Chengsheng" last="Zhang">Chengsheng Zhang</name>
<name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
</noCountry>
<country name="Canada"><region name="Ontario"><name sortKey="Lin, Han Xin" sort="Lin, Han Xin" uniqKey="Lin H" first="Han-Xin" last="Lin">Han-Xin Lin</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002368 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002368 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:21798295 |texte= Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:21798295" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |